Breakthrough Infections Update

Céline Gounder discusses the prevalence of breakthrough infections among fully vaccinated individuals, highlighting differences between Pfizer, Moderna, and Johnson & Johnson vaccines. With ongoing studies and potential dosing regimen adjustments, insights into vaccine efficacy are evolving.